Marker Therapeutics, Inc.
Records under this name other than patents Marker Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Marker Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,030,252 | Chimeric Nucleic Acid Molecules with Non-Aug Translation Initiation Sequences and Uses Thereof Lapsed on the fee record Ended Jul 24, 2026 · High confidence | Lapsed on the fee record | Ended Jul 24, 2026 | High confidence |
| US 9,364,523 | A chimeric nucleic acid molecule with non-AUG translation initiation sequences Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 9,988,643 | Chimeric Nucleic Acid Molecules with Non-Aug Translation Initiation Sequences and Uses Thereof Lapsed on the fee record Ended Jun 5, 2022 · High confidence | Lapsed on the fee record | Ended Jun 5, 2022 | High confidence |
| US 9,655,956 | Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof Lapsed on the fee record Ended May 23, 2021 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2021 | From the USPTO record |